Home › Funds › SCOGGIN MANAGEMENT LP › LENZ

SCOGGIN MANAGEMENT LP position in LENZ

LENZ THERAPEUTICS INC · Health Care

SCOGGIN MANAGEMENT LP reported holding 150,000 shares of LENZ (LENZ THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$576K, representing 0.11% of its reported portfolio and ranking #33 among its reported holdings. SCOGGIN MANAGEMENT LP has disclosed LENZ holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)150.00K sh
Reported value held$576.00K
Portfolio Weight0.11%
First reportedQ1 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How SCOGGIN MANAGEMENT LP's LENZ position evolved

SCOGGIN MANAGEMENT LP first disclosed a stake in LENZ in Q1 2025 at 100,000 shares (US$2.6M). The position peaked in Q3 2025 at 225,000 shares, worth US$10.5M. Across 7 filings, SCOGGIN MANAGEMENT LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 150,000 shares valued at US$576K — a reduction of -25,000 shares quarter over quarter.. Notable position changes include a 100% increase in Q2 2025 (shares rose 59% over the following quarter), a 44% trim in Q4 2025 (shares fell 43% over the following quarter), a 40% increase in Q2 2026 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 100.00K $2.57M New
Q2 2025 200.00K $5.86M Add
Q3 2025 225.00K $10.48M Add
Q4 2025 125.00K $2.00M Reduce
Q1 2026 125.00K $1.14M Hold
Q2 2026 175.00K $994.00K Add
Q3 2026 150.00K $576.00K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LENZ and 13F data

LENZ (LENZ THERAPEUTICS INC) is a Health Care company. 18 other funds we track also report a position in LENZ — the largest reported positions include Alpha Wave Global, LP (US$13.9M), Versant Venture Management, LLC (US$10.2M), 72 Investment Holdings, LLC (US$5.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LENZ

All LENZ fund holders →

FAQ

How long has SCOGGIN MANAGEMENT LP held LENZ?

SCOGGIN MANAGEMENT LP has disclosed LENZ holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is SCOGGIN MANAGEMENT LP's current position in LENZ?

As of Q3 2026, SCOGGIN MANAGEMENT LP holds 150.00K shares of LENZ (LENZ THERAPEUTICS INC), valued at $576.00K, representing 0.11% of its reported portfolio and ranking #33.

Has SCOGGIN MANAGEMENT LP been buying or selling LENZ?

In the latest 13F filing (Q3 2026), SCOGGIN MANAGEMENT LP reduced its position in LENZ. The position peaked in Q3 2025 at 225.00K shares.

Which other funds hold LENZ?

Other major institutional holders of LENZ include Alpha Wave Global, LP, Versant Venture Management, LLC, 72 Investment Holdings, LLC, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.